BRIEF-Cspc Pharmaceutical's Recombinant Herpes Zoster Vaccine (Sys6052) Obtains FDA Clinical Trial Approval In U.S.

0

Sept 29 (Reuters) – CSPC PHARMACEUTICAL GROUP LIMITED : * PHARMA'S RECOMBINANT HERPES ZOSTER VACCINE (SYS6052) OBTAINS FDA CLINICAL TRIAL APPROVAL IN U.S. Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)